JOSEPHINE RODRIGUEZ: Open Payments
NPI 1952165003 · NEWARK, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$539 in 25 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $446 · 2025 $539
Food & beverage: $539
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 4 | $176 |
| Otsuka America Pharmaceutical, Inc. | 6 | $113 |
| ABBVIE INC. | 6 | $90 |
| Teva Pharmaceuticals USA, Inc. | 2 | $37 |
| Vanda Pharmaceuticals Inc. | 2 | $34 |
| Lundbeck LLC | 1 | $19 |
| E.R. Squibb & Sons, L.L.C. | 1 | $18 |
| Janssen Pharmaceuticals, Inc | 1 | $18 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $17 |
| Axsome Therapeutics, Inc. | 1 | $17 |
Products named: LYBALVI, VRAYLAR, REXULTI, ARISTADA, ABILIFY ASIMTUFII, UZEDY, FANAPT, ABILIFY MAINTENA.
Industry payments across NJ — which companies pay providers there.
